The Valley Desk

LetterAmerican journal of hematologyPublished

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

12 of 33 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Letter
Venue
American journal of hematology
Published
Subject terms
Chronic Lymphocytic Leukemia; Bruton Tyrosine Kinase Inhibitor; Venetoclax; Real‐world Outcomes
PubMed ID
39698781
PubMed Central ID
PMC11803543
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal